sALS and fALS share several features, including protein aggregation, motor neuron hyperexcitability, trafficking defects, disruption of nucleocytoplasmic transport, oxidative stress, mitochondrial dysfunction, glutamate excitotoxicity, and neuroinflammation
In a statement, Novo Nordisk President and CEO Mike Doustdar said, Novo Nordisk has always worked to secure affordable access to our innovative medicines, and todays announcement will bring semaglutide medicines to more American patients at a lower cost
While the study was observational (meaning that causality cant be confirmed), it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, says lead author, Professor Elizabeth McDonald
RGA study reveals: By 2045, GLP-1s could reduce mortality by 3.5% in the US, 2.6% in Canada, 2% in the UK, and 1.4% in Hong Kong
Medication can help manage these systems, but long-term success is usually strongest when pharmacological treatment is combined with structured lifestyle support.